Sanofi SA ended the second quarter with a small 1.5% decline in net sales to €9.965 billion – a figure that was affected by movements in exchange rates. When measured in constant exchange rates, sales showed an increase of 3.3%. For the half year, net sales were €20.2 billion, up by 4.4% at constant exchange rates.
